Moreover, C3 knockdown reversed the sensitivity of tumor cells to PTX treatment and had no effect on proliferation, indicating that C3 regulated NSCLC PTX resistance in a C3a/C3aR/PI3K/AKT-independent manner. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.